162 related articles for article (PubMed ID: 28860931)
1. The effect of pentoxifylline on L-1 sarcoma tumor growth and angiogenesis in Balb/c mice.
Bałan BJ; Demkow U; Skopiński P; Bychawska M; Skopińska-Różewska E; Lewicki S; Zdanowski R
Cent Eur J Immunol; 2017; 42(2):131-139. PubMed ID: 28860931
[TBL] [Abstract][Full Text] [Related]
2. Synergistic Activity for Natural and Synthetic Inhibitors of Angiogenesis Induced by Murine Sarcoma L-1 and Human Kidney Cancer Cells.
Bałan BJ; Siwicki AK; Pastewka K; Demkow U; Skopiński P; Skopińska-Różewska E; Lewicki S; Zdanowski R
Adv Exp Med Biol; 2017; 1020():91-104. PubMed ID: 28456932
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of herbal remedy PERVIVO and anti-inflammatory drug sulindac on L-1 sarcoma tumor growth and tumor angiogenesis in Balb/c mice.
Skopiński P; Bałan BJ; Kocik J; Zdanowski R; Lewicki S; Niemcewicz M; Gawrychowski K; Skopińska-Różewska E; Stankiewicz W
Mediators Inflamm; 2013; 2013():289789. PubMed ID: 23935247
[TBL] [Abstract][Full Text] [Related]
4. Reversal of Osteopenia in Ovariectomized Rats by Pentoxifylline: Evidence of Osteogenic and Osteo-Angiogenic Roles of the Drug.
Pal S; Porwal K; Singh H; Malik MY; Rashid M; Kulkarni C; Khan Y; Jagavelu K; Wahajuddin M; Chattopadhyay N
Calcif Tissue Int; 2019 Sep; 105(3):294-307. PubMed ID: 31175387
[TBL] [Abstract][Full Text] [Related]
5. The anti-inflammatory effects of the phosphodiesterase inhibitor pentoxifylline in the rat.
Abdel-Salam OM; Baiuomy AR; El-Shenawy SM; Arbid MS
Pharmacol Res; 2003 Apr; 47(4):331-40. PubMed ID: 12644391
[TBL] [Abstract][Full Text] [Related]
6. Pentoxifylline inhibits melanoma tumor growth and angiogenesis by targeting STAT3 signaling pathway.
Kamran MZ; Gude RP
Biomed Pharmacother; 2013 Jun; 67(5):399-405. PubMed ID: 23639230
[TBL] [Abstract][Full Text] [Related]
7. Expression of adenosine receptors and vegf during angiogenesis and its inhibition by pentoxifylline-A study using zebrafish model.
Nathan JR; Lakshmanan G; Michael FM; Seppan P; Ragunathan M
Biomed Pharmacother; 2016 Dec; 84():1406-1418. PubMed ID: 27802896
[TBL] [Abstract][Full Text] [Related]
8. Pentoxifylline inhibits human T-cell adhesion to dermal endothelial cells.
Bruynzeel I; van der Raaij LM; Willemze R; Stoof TJ
Arch Dermatol Res; 1997 Mar; 289(4):189-93. PubMed ID: 9143734
[TBL] [Abstract][Full Text] [Related]
9. The effect of pentoxifylline on spontaneous and experimental metastasis of the mouse Neuro2a neuroblastoma.
Amirkhosravi A; Warnes G; Biggerstaff J; Malik Z; May K; Francis JL
Clin Exp Metastasis; 1997 Jul; 15(4):453-61. PubMed ID: 9219735
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of endothelial cell proliferation and tumor-induced angiogenesis by pentoxifylline.
Gude RP; Binda MM; Boquete AL; Bonfil RD
J Cancer Res Clin Oncol; 2001 Oct; 127(10):625-30. PubMed ID: 11599799
[TBL] [Abstract][Full Text] [Related]
11. Preclinical evaluation of the antimetastatic efficacy of Pentoxifylline on A375 human melanoma cell line.
Kamran MZ; Gude RP
Biomed Pharmacother; 2012 Dec; 66(8):617-26. PubMed ID: 23089470
[TBL] [Abstract][Full Text] [Related]
12. Effects of pentoxifylline, pentifylline and gamma-interferon on proliferation, differentiation, and matrix synthesis of human renal fibroblasts.
Strutz F; Heeg M; Kochsiek T; Siemers G; Zeisberg M; Müller GA
Nephrol Dial Transplant; 2000 Oct; 15(10):1535-46. PubMed ID: 11007820
[TBL] [Abstract][Full Text] [Related]
13. Pentoxifylline induces apoptosis of HepG2 cells by reducing reactive oxygen species production and activating the MAPK signaling.
Wang Y; Dong L; Li J; Luo M; Shang B
Life Sci; 2017 Aug; 183():60-68. PubMed ID: 28583366
[TBL] [Abstract][Full Text] [Related]
14. Oral dosing of pentoxifylline, a pan-phosphodiesterase inhibitor restores bone mass and quality in osteopenic rabbits by an osteogenic mechanism: A comparative study with human parathyroid hormone.
Pal S; Porwal K; Khanna K; Gautam MK; Malik MY; Rashid M; Macleod RJ; Wahajuddin M; Parameswaran V; Bellare JR; Chattopadhyay N
Bone; 2019 Jun; 123():28-38. PubMed ID: 30858147
[TBL] [Abstract][Full Text] [Related]
15. Parsimonious Effect of Pentoxifylline on Angiogenesis: A Novel Pentoxifylline-Biased Adenosine G Protein-Coupled Receptor Signaling Platform.
Khoury W; Trus R; Chen X; Baghaie L; Clark M; Szewczuk MR; El-Diasty M
Cells; 2023 Apr; 12(8):. PubMed ID: 37190108
[TBL] [Abstract][Full Text] [Related]
16. Pentoxifylline in the treatment of intermittent claudication of the lower limbs.
Reich T; Cutler BC; Lee BY; Porter JM; Reichle FA; Scogin JT; Strandness DE
Angiology; 1984 Jul; 35(7):389-95. PubMed ID: 6380347
[TBL] [Abstract][Full Text] [Related]
17. Modulation of inflammatory response by pentoxifylline is independent of heme oxygenase-1 pathway.
Taha H; Grochot-Przeczek A; Was H; Kotlinowski J; Kozakowska M; Marek A; Skrzypek K; Lackowska B; Balcerczyk A; Mustafa S; Dulak J; Jozkowicz A
J Physiol Pharmacol; 2009 Jun; 60(2):3-12. PubMed ID: 19617639
[TBL] [Abstract][Full Text] [Related]
18. Pentoxifylline: a drug with wide spectrum applications in dermatology.
Zargari O
Dermatol Online J; 2008 Nov; 14(11):2. PubMed ID: 19094840
[TBL] [Abstract][Full Text] [Related]
19. Pentoxifylline inhibits the synthesis and IFN-gamma-inducing activity of IL-18.
Samardzic T; Jankovic V; Stosic-Grujicic S; Popadic D; Trajkovic V
Clin Exp Immunol; 2001 May; 124(2):274-81. PubMed ID: 11422205
[TBL] [Abstract][Full Text] [Related]
20. The phosphodiesterase inhibitors pentoxifylline and rolipram prevent diabetes in NOD mice.
Liang L; Beshay E; Prud'homme GJ
Diabetes; 1998 Apr; 47(4):570-5. PubMed ID: 9568689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
